Edwin G. 

Canada’s Drug Agency recommends public drug plans not to cover lecanemab

https://www.cbc.ca/news/health/lecanemab-canada-drug-agency-9.7098356
- - -
L’Agence des médicaments du Canada recommande aux programmes d’assurance-médicaments publics de ne pas couvrir le lécanémab

// Article en anglais //

#Canada #Alzheimer #lecanemab #Health #Santé

New Alzheimer's drug, lecanemab, not recommended for listing on Canada's public drug plans | CBC News

Public drug plans should not cover lecanemab, a drug to slow early-stage Alzheimer's disease, Canada's Drug Agency says in its draft recommendation.

CBC
Feb 20 at 1:46amWeb